Heinonen T H
Biochem Pharmacol. 1984 May 15;33(10):1585-93. doi: 10.1016/0006-2952(84)90278-8.
Metabolism of vinyltoluene was studied in rats after injecting different doses of vinyltoluene. The main metabolites excreted in urine of rats after vinyltoluene treatment were: thioethers, p- methylmandelic acid, p- methylphenylglyoxylic acid, p- methylbenzoyl glycine, p- methylphenylacetyl glycine and p- vinylbenzoyl glycine. The highest excretion rate was obtained with doses of 50, 250 and 500 mg/kg already within the first six ours. However, the dose of 500 mg/kg did not increase the excretion rates of these metabolites compared to the dose of 250 mg/kg suggesting that the metabolic pathways begin to be saturated with the amount of 250 mg/kg. At the dose of 50 mg/kg 55% of the dose was detected as urinary metabolites within 23 hr, mainly within the first 6 hr. The amounts of the excreted metabolites expressed as per cent of the injected dose (250 mg/kg or 500 mg/kg) were lower than that caused by 50 mg/kg, and a noticeable amount of the total sums were excreted within 11-23 hr suggesting that the excretion was still continued with the doses of 250 and 500 mg/kg 23 hr after the injection. The excretion of all analyzed metabolites of vinyltoluene was prevented by the pretreatment of the rats with 1- phenylimidazole , an inhibitor of cytochrome P-450 monoxygenases. This indicates that these metabolites were formed as catalyzed by cytochrome P-450. The structures of the analyzed metabolites suggest that the main reactive intermediate of vinyltoluene is vinyltoluene-7,8-oxide. Furthermore, the amounts of the excreted metabolites showed that the main detoxification pathways of v inyltoluene -7,8-oxide were the conjugation with reduced glutathione and hydration to diols. Pre-treatment of the rats with PCBs increased the excretion rates of the metabolites. However, the PCB-pretreated rats excreted less thioethers (62%) compared to the rats treated only with the same amount of vinyltoluene whereas the total sum of the other metabolites was about the same in these both groups. This result suggests that PCBs change the metabolism of vinyltoluene to some other pathway which could be glucuronide conjugation because PCBs increased the activity of UDP glucuronosyltransferase in a dose-dependent manner.
给大鼠注射不同剂量的乙烯基甲苯后,对其体内乙烯基甲苯的代谢情况进行了研究。乙烯基甲苯处理后,大鼠尿液中排出的主要代谢产物有:硫醚、对甲基扁桃酸、对甲基苯甲酰甲酸、对甲基苯甲酰甘氨酸、对甲基苯乙酰甘氨酸和对乙烯基苯甲酰甘氨酸。在前6小时内,50、250和500毫克/千克剂量组的排泄率最高。然而,与250毫克/千克剂量相比,500毫克/千克剂量并未增加这些代谢产物的排泄率,这表明代谢途径在250毫克/千克剂量时开始饱和。在50毫克/千克剂量下,23小时内有55%的剂量以尿液代谢产物的形式被检测到,主要在最初6小时内。以注射剂量(250毫克/千克或500毫克/千克)的百分比表示的排泄代谢产物量低于50毫克/千克剂量组,且在11 - 23小时内排泄了相当数量的总量,这表明在注射23小时后,250和500毫克/千克剂量的乙烯基甲苯仍在持续排泄。用细胞色素P - 450单加氧酶抑制剂1 - 苯基咪唑预处理大鼠可阻止乙烯基甲苯所有分析代谢产物的排泄。这表明这些代谢产物是由细胞色素P - 450催化形成的。分析代谢产物的结构表明,乙烯基甲苯的主要反应中间体是乙烯基甲苯 - 7,8 - 环氧化物。此外,排泄代谢产物的量表明,乙烯基甲苯 - 7,8 - 环氧化物的主要解毒途径是与还原型谷胱甘肽结合并水化生成二醇。用多氯联苯预处理大鼠可提高代谢产物的排泄率。然而,与仅用相同量乙烯基甲苯处理的大鼠相比,多氯联苯预处理的大鼠排泄的硫醚较少(62%),而这两组中其他代谢产物的总量大致相同。这一结果表明,多氯联苯将乙烯基甲苯的代谢改变为其他途径,可能是葡糖醛酸结合途径,因为多氯联苯以剂量依赖的方式增加了UDP葡糖醛酸基转移酶的活性。